Cipla eyes India's weight management space as demand soars: MD Umang Vohra Ruchika Sharma14 July 2025 12:30 PM ISTMumbai: Mumbai-based pharma giant Cipla is gearing up to make an entry into India's rapidly growing weight management market, according to Umang...
Post WHO alert, Novo Nordisk seeks EMA nod for higher dose of obesity treatment Wegovy Ruchika Sharma9 July 2025 11:36 AM ISTDenmark: Following a recent World Health Organization (WHO) alert on semaglutide-containing medicines, Novo Nordisk has announced the...
Weight loss drug: Novo Nordisk Wegovy now available in India Ruchika Sharma25 Jun 2025 3:52 PM ISTMumbai: Novo Nordisk, a global healthcare company headquartered in Denmark, has announced the launch of Wegovy (injectable Semaglutide)...
Novo Nordisk Told to Increase Indian Patient Enrollment for Ziltivekimab Study Dr. Divya Colin19 Jun 2025 7:36 PM ISTNew Delhi: In response to a proposal by Novo Nordisk, the Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO)...
Novo Nordisk, Deep Apple Therapeutics ink pact to develop oral therapeutics for Cardiometabolic Diseases Ruchika Sharma12 Jun 2025 10:00 AM ISTSouth San Francisco: Deep Apple Therapeutics, Inc. has announced a research collaboration and exclusive worldwide license agreement with Novo...
Delhi HC Restrains Dr Reddy's from Selling Semaglutide Drug in India Amid Novo Nordisk Row Ruchika Sharma31 May 2025 6:19 PM ISTNovo Nordisk has accused Dr Reddy's and OneSource of importing semaglutide API and using it to make and export formulations.
Lars Fruergaard Jorgensen to step down as CEO of Novo Nordisk Ruchika Sharma18 May 2025 10:45 AM ISTDenmark: Novo Nordisk has announced that Lars Fruergaard Jorgensen will step down from his role as CEO of Novo Nordisk. He will continue as CEO...
WHO to back use of weight-loss drugs as obesity treatment in adults Ruchika Sharma5 May 2025 11:00 AM ISTLondon: The World Health Organization (WHO) is set to officially back the use of weight-loss drugs as a treatment for obesity in adults for the...
Novo Nordisk application for oral Wegovy accepted by USFDA for weight loss Ruchika Sharma3 May 2025 3:21 PM ISTPlainsboro: Novo Nordisk has announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submission for an...
Novo Nordisk Withdrawal to Reshape Insulin Market; Lupin's Huminsulin to Gain Spotlight Farhat Nasim24 April 2025 6:29 PM ISTMumbai: Amidst the ongoing news of conventional insulin market disruption and growing concern over potential shortages triggered by Novo...
As Ozempic, Wegovy Take Priority, Novo Nordisk Winds Down Insulin Portfolio In India Farhat Nasim22 April 2025 7:04 PM ISTNew Delhi: Danish pharmaceutical giant Novo Nordisk has announced plans to phase out Human Mixtard, India's top-selling insulin brand. This...
Conduct CT in India: CDSCO Panel tells Novo Nordisk India For new formulation of Semaglutide tablets Dr. Divya Colin17 April 2025 5:30 PM ISTNew Delhi: In line with the proposal for approval of Semaglutide tablets 1.5 mg, 4 mg, 9 mg of new formulation based on the bioequivalence (BE)...
